1. Home
  2. EAD vs BWAY Comparison

EAD vs BWAY Comparison

Compare EAD & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Income Opportunities Fund

EAD

Allspring Income Opportunities Fund

HOLD

Current Price

$6.47

Market Cap

391.8M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$13.64

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EAD
BWAY
Founded
2003
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
391.8M
450.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EAD
BWAY
Price
$6.47
$13.64
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.25
AVG Volume (30 Days)
154.0K
140.9K
Earning Date
01-01-0001
03-11-2026
Dividend Yield
8.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$301.23
Revenue Next Year
N/A
$24.33
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$5.89
$7.84
52 Week High
$7.18
$26.63

Technical Indicators

Market Signals
Indicator
EAD
BWAY
Relative Strength Index (RSI) 27.12 31.67
Support Level N/A $11.55
Resistance Level $6.91 $14.14
Average True Range (ATR) 0.08 0.79
MACD -0.02 -0.08
Stochastic Oscillator 2.78 15.84

Price Performance

Historical Comparison
EAD
BWAY

About EAD Allspring Income Opportunities Fund

Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: